Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
1.420
-0.055 (-3.73%)
At close: Sep 3, 2026, 4:00 PM EDT
1.420
0.00 (0.00%)
Pre-market: Sep 4, 2026, 7:00 AM EDT
Codexis Employees
Codexis had 146 employees as of December 31, 2025. The number of employees decreased by 42 or -22.34% compared to the previous year.
Employees
146
Change (1Y)
-42
Growth (1Y)
-22.34%
Revenue / Employee
$532,048
Profits / Employee
-$210,432
Market Cap
155.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 146 | -42 | -22.34% | 146 | 0 |
| Dec 31, 2024 | 188 | 14 | 8.05% | 188 | 0 |
| Dec 31, 2023 | 174 | -74 | -29.84% | 174 | 0 |
| Dec 31, 2022 | 248 | -13 | -4.98% | 248 | 0 |
| Dec 31, 2021 | 261 | 80 | 44.20% | 261 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Molecular Partners AG | 134 |
| MediWound | 121 |
| Caribou Biosciences | 97 |
| Tenaya Therapeutics | 70 |
| Milestone Pharmaceuticals | 38 |
| Jyong Biotech | 27 |
| Spruce Biosciences | 22 |
CDXS News
- 7 days ago - Codexis to Participate in Cantor Global Healthcare Conference 2026 - GlobeNewsWire
- 18 days ago - Codexis reports Q2 EPS (13c), consensus (12c) - TheFly
- 18 days ago - Codexis backs FY26 revenue view $72M-$76M, consensus $74.1M - TheFly
- 18 days ago - Codexis price target lowered to $8 from $9 at Piper Sandler - TheFly
- 23 days ago - Codexis Earnings Call Transcript: Q2 2026 - Transcripts
- 23 days ago - Codexis Quarterly report: Q2 2026 - Filings
- 23 days ago - Codexis Earnings release: Q2 2026 - Filings
- 23 days ago - Codexis Reports Second Quarter 2026 Financial Results - GlobeNewsWire